X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1876) 1876
Book Review (725) 725
Publication (111) 111
Book Chapter (24) 24
Conference Proceeding (7) 7
Book / eBook (1) 1
Dissertation (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1483) 1483
humans (1399) 1399
female (878) 878
recurrent venous thromboembolism (848) 848
hematology (595) 595
risk factors (501) 501
male (486) 486
adult (479) 479
peripheral vascular disease (470) 470
pregnancy (416) 416
middle aged (413) 413
deep-vein thrombosis (412) 412
thrombosis (407) 407
venous thromboembolism (390) 390
anticoagulants - therapeutic use (356) 356
molecular-weight heparin (328) 328
aged (311) 311
thromboembolism (303) 303
risk (289) 289
anticoagulants (279) 279
thrombophilia (265) 265
factor-v-leiden (254) 254
recurrence (239) 239
prevention (233) 233
risk-factors (231) 231
pulmonary embolism (213) 213
medicine, general & internal (212) 212
pulmonary-embolism (202) 202
cancer (201) 201
venous thrombosis (186) 186
abridged index medicus (176) 176
treatment outcome (169) 169
antiphospholipid syndrome (167) 167
medicine & public health (167) 167
oncology (167) 167
warfarin (166) 166
activated protein-c (162) 162
recurrent pregnancy loss (158) 158
obstetrics & gynecology (151) 151
women (150) 150
care and treatment (149) 149
anticoagulation (148) 148
anticoagulants - administration & dosage (141) 141
recurrent miscarriage (140) 140
therapy (137) 137
anticardiolipin antibodies (133) 133
retrospective studies (133) 133
mutation (132) 132
prospective studies (129) 129
recurrent thrombosis (128) 128
thrombophilia - genetics (126) 126
thrombophilia - complications (124) 124
antiphospholipid antibodies (120) 120
aged, 80 and over (119) 119
health aspects (117) 117
factor v - genetics (116) 116
risk assessment (116) 116
diagnosis (115) 115
management (115) 115
heparin (114) 114
anticoagulants - adverse effects (113) 113
heparin, low-molecular-weight - therapeutic use (113) 113
young adult (112) 112
adolescent (107) 107
case-control studies (107) 107
neoplasms - complications (106) 106
d-dimer (102) 102
prevalence (101) 101
venous thrombosis - drug therapy (100) 100
cardiac & cardiovascular systems (99) 99
research (98) 98
hematology, oncology and palliative medicine (97) 97
oral anticoagulant-therapy (97) 97
thrombosis - etiology (95) 95
analysis (93) 93
disease (91) 91
prognosis (91) 91
surgery (91) 91
antiphospholipid syndrome - complications (90) 90
antithrombotic therapy (90) 90
mortality (90) 90
long-term (89) 89
systemic-lupus-erythematosus (89) 89
drug therapy (88) 88
inherited thrombophilia (88) 88
stroke (88) 88
thrombophilia - diagnosis (88) 88
time factors (88) 88
chemotherapy (86) 86
prothrombin - genetics (86) 86
secondary prevention (86) 86
fetal loss (85) 85
intensity warfarin therapy (85) 85
low-dose aspirin (82) 82
thrombin (81) 81
pulmonary embolism - drug therapy (80) 80
follow-up studies (79) 79
venous thromboembolism - drug therapy (79) 79
cohort studies (78) 78
miscarriage (78) 78
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1759) 1759
French (58) 58
German (53) 53
Spanish (18) 18
Japanese (4) 4
Polish (4) 4
Russian (4) 4
Portuguese (3) 3
Czech (1) 1
Hungarian (1) 1
Romanian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Thrombosis and Haemostasis, ISSN 0340-6245, 05/2018, Volume 118, Issue 5, pp. 914 - 921
Abstract Objective  This article assesses the impact of renal impairment (RI) on the efficacy and safety of anticoagulation in patients with cancer-associated... 
Stroke, Systemic or Venous Thromboembolism | cancer-associated thrombosis | recurrent venous thromboembolism | tinzaparin | anticoagulation | renal impairment
Journal Article
Journal Article
THROMBOSIS AND HAEMOSTASIS, ISSN 0340-6245, 05/2018, Volume 118, Issue 5, pp. 914 - 921
Objective This article assesses the impact of renal impairment (RI) on the efficacy and safety of anticoagulation in patients with cancer-associated thrombosis... 
cancer-associated thrombosis | anticoagulation | RANDOMIZED CLINICAL-TRIAL | INSUFFICIENCY | GLOMERULAR-FILTRATION-RATE | RIETE REGISTRY | ANTICOAGULANT TREATMENT | WARFARIN | tinzaparin | MOLECULAR-WEIGHT HEPARIN | ELDERLY PATIENTS | PERIPHERAL VASCULAR DISEASE | recurrent venous thromboembolism | COMPLICATIONS | HEMATOLOGY | renal impairment
Journal Article
Journal Article
Annals of Hematology, ISSN 0939-5555, 1/2019, Volume 98, Issue 1, pp. 93 - 100
Venous thromboembolism (VTE) is a major burden in patients with BCR-ABL-negative myeloproliferative neoplasms (MPN). In addition to cytoreductive treatment... 
Oncology | Recurrent venous thromboembolism | Medicine & Public Health | Hematology | Anticoagulation therapy | Myeloproliferative neoplasms | MYELOFIBROSIS | POLYCYTHEMIA-VERA | ORAL RIVAROXABAN | THROMBOSIS | HYDROXYUREA | ANAGRELIDE | INTENSITY | ESSENTIAL THROMBOCYTHEMIA | PROPHYLAXIS | HEMATOLOGY | EPIDEMIOLOGY | Thromboembolism | Patients | Tumors | Index Medicus
Journal Article
Journal Article
Journal Article
Journal of Thrombosis and Haemostasis, ISSN 1538-7933, 04/2018, Volume 16, Issue 4, pp. 680 - 688
Background: Mild antithrombin deficiency (previously defined as antithrombin activity below 70% or 80%) has been associated with a 2.4-3.5-fold increased risk... 
antithrombin | recurrent venous thromboembolism | deficiency | level | risk factor | EVENTS | THROMBOSIS | HEPARIN | PROSPECTIVE COHORT | 1ST | THROMBOPHILIA | PERIPHERAL VASCULAR DISEASE | ABSENCE | HEMATOLOGY | Thromboembolism | Risk factors | Drinking behavior | Population studies | Health risk assessment | Antithrombin | Thrombosis | Index Medicus
Journal Article
16.